A research team from KAIST has revealed that depression is not merely a problem of the mind or brain, but is deeply connected to abnormalities in the body’s overall immune response.
They found that this immune abnormality affects brain function, and the “Immune Neural Axis” imbalance is the core mechanism of depression, opening up the possibility for the discovery of new biomarkers and the development of new drugs for depression treatment.
https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202508383
Dr. Reinhardt: This is early exploratory work, but accepting their findings leads to the question, “What can we do with natural herbs to counter this imbalance?”
A deep dive (with the help of AI, of course) turned up a surprisingly simple list of herbs with scientific support, and can even be interpreted as new scientific insight to why these long used herbs may work. The following are listed by order of importance in exploring your own supplement strategy. Links are given to high quality and cost-effective Amazon matching herbs. Note: these are suggestions for doing your own research, they are not intended as a recommendation or prescription.
- Ashwagandha: Benefits across all four key pathways. Range studied: 300–600 mg/day standardized root extract for 8–12 weeks. https://amzn.to/47S5JkI
- Rhodiola rosea: Regulates HTR2C and stress-response genes. Range: 200–600 mg/day. https://amzn.to/4rjiMDu
- Curcumin: Modulates serotonin signaling and BDNF pathways, neuroinflammation, and cellular stress. Range: 500–1,000 mg/day of bioavailable curcumin. https://amzn.to/4pnbblp
- Lion’s Mane mushroom (Hericium erinaceus): Most direct match to neurodevelopmental disruption (DCC, CHL1, DCLK3). Range: ≈1–3 g/day powdered fruiting body or ~500–1,000 mg/day standardized extract. https://amzn.to/4r8ab6l
- Panax ginseng: Modulates serotonin receptors and cellular energy metabolism. Range: 200–400 mg/day standardized extract. https://amzn.to/4oNbm9M
- Bacopa monnieri: Strong neurotrophic and synaptogenic effects. Range: ~300–450 mg/day standardized extract. https://amzn.to/3LR4Q3m
Combination products are also available, but it is hard to find combinations with full therapeutic levels.
A more detailed analysis
New research using patient-derived brain organoids has opened an entirely new window into understanding why some cases of major depression are unusually resistant to stress. These organoids—miniature, simplified neural systems—allow scientists to watch how brain cells respond when stress hormones are applied. The emerging picture is surprisingly consistent: certain individuals show heightened biological vulnerability, with rapid changes in genes involved in wiring, development, serotonin signaling, and cellular stress responses.
Several key pathways appear central. Genes such as DCC, CHL1, and DCLK3—responsible for axon guidance and neural maturation—shift abnormally under stress, suggesting that the brain’s ‘wiring blueprint’ becomes destabilized. Serotonin-related genes like HTR2C and the melanin-concentrating hormone gene PMCH also show dysregulation, which may affect mood, sleep, and stress sensitivity. Meanwhile, stress-response proteins such as HSPA6 become amplified, reflecting a system under strain. Notably, plasma proteins in these individuals often mirror the brain organoid changes, meaning blood biomarkers may eventually help identify these stress-sensitive phenotypes.
While this research is still early, it raises an intriguing question: can natural compounds that modulate these same pathways offer support? A growing literature suggests they may. For HPA-axis hyperactivation—the biological core of chronic stress—botanicals such as Ashwagandha, Rhodiola, and Schisandra have demonstrated cortisol-lowering and resilience-enhancing effects in clinical trials. For neurodevelopmental pathways, Lion’s Mane mushroom, Panax ginseng, and Bacopa have each shown the ability to promote neuronal growth, synaptic plasticity, or axonal repair. Serotonin-related dysregulation maps well to compounds like Rhodiola, Curcumin, and green tea catechins (EGCG), all of which influence serotonergic tone or 5-HT2C receptor pathways. And for cellular stress responses, including heat‑shock proteins, botanicals such as Reishi, Ashwagandha, and Curcumin have been shown to normalize protein-folding stress markers.
Taken together, these findings hint at a future in which depression treatment may become more biologically tailored—matching molecular signatures to specific nutritional or botanical supports. For now, the evidence remains early-stage, and these natural agents should be considered adjunctive, not primary treatments. Still, the convergence between organoid biology and existing nutraceutical research suggests that integrative, personalized strategies for depression may be closer than we think.
Gene–Pathway to Herb Mapping (Conceptual)
| Pathway / Marker | Key Functions / Issues in MDD | Natural Agents with Mechanistic Overlap |
| DCC, CHL1, DCLK3 (axon guidance, neural development) | Neuronal migration, axon guidance, synaptic maturation; vulnerability of developing circuits under stress. | Lion’s Mane (Hericium erinaceus), Bacopa monnieri, Panax ginseng, Ashwagandha |
| HTR2C, PMCH (serotonin 2C, melanin-concentrating hormone) | Mood regulation, appetite, sleep; altered expression in stress and depression models. | Rhodiola rosea, Curcumin, Panax ginseng, Green tea catechins (EGCG) |
| HSPA6, LRRC75A (heat-shock and cellular stress response) | Protein folding, cellular stress resilience, chaperone systems. | Ashwagandha, Rhodiola rosea, Reishi (Ganoderma), Curcumin |
| HPA-axis hyperreactivity / neuroinflammation | Elevated cortisol, CRH, ACTH; increased inflammatory cytokines and neural vulnerability. | Ashwagandha, Rhodiola rosea, Schisandra chinensis, Curcumin, EGCG |
| Trans-compartmental markers (DCLK3, CALY) | Cross-talk between peripheral and central stress signatures; synaptic and mitochondrial functions. | Panax ginseng, Lion’s Mane, Rhodiola, Curcumin |